CN110639018B - 一种防治老年性高血压的药物组合物及其用途 - Google Patents
一种防治老年性高血压的药物组合物及其用途 Download PDFInfo
- Publication number
- CN110639018B CN110639018B CN201911111269.6A CN201911111269A CN110639018B CN 110639018 B CN110639018 B CN 110639018B CN 201911111269 A CN201911111269 A CN 201911111269A CN 110639018 B CN110639018 B CN 110639018B
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- trifluoromethyl
- phenyl
- hypertension
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Chemistry (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911111269.6A CN110639018B (zh) | 2019-11-14 | 2019-11-14 | 一种防治老年性高血压的药物组合物及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911111269.6A CN110639018B (zh) | 2019-11-14 | 2019-11-14 | 一种防治老年性高血压的药物组合物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110639018A CN110639018A (zh) | 2020-01-03 |
CN110639018B true CN110639018B (zh) | 2020-06-26 |
Family
ID=68995882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911111269.6A Active CN110639018B (zh) | 2019-11-14 | 2019-11-14 | 一种防治老年性高血压的药物组合物及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110639018B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005100298A1 (en) * | 2004-04-13 | 2005-10-27 | Merck & Co., Inc. | Cetp inhibitors |
WO2010039474A1 (en) * | 2008-10-01 | 2010-04-08 | Merck Sharp & Dohme Corp. | Prodrugs of oxazolidinone cetp inhibitors |
WO2011058975A1 (ja) * | 2009-11-11 | 2011-05-19 | 国立大学法人富山大学 | 食後過血糖改善剤、およびピロリジン型イミノ糖またはその塩 |
WO2013063217A1 (en) * | 2011-10-28 | 2013-05-02 | Merck Sharp & Dohme Corp. | Fused bicyclic oxazolidinone cetp inhibitor |
-
2019
- 2019-11-14 CN CN201911111269.6A patent/CN110639018B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005100298A1 (en) * | 2004-04-13 | 2005-10-27 | Merck & Co., Inc. | Cetp inhibitors |
WO2010039474A1 (en) * | 2008-10-01 | 2010-04-08 | Merck Sharp & Dohme Corp. | Prodrugs of oxazolidinone cetp inhibitors |
WO2011058975A1 (ja) * | 2009-11-11 | 2011-05-19 | 国立大学法人富山大学 | 食後過血糖改善剤、およびピロリジン型イミノ糖またはその塩 |
WO2013063217A1 (en) * | 2011-10-28 | 2013-05-02 | Merck Sharp & Dohme Corp. | Fused bicyclic oxazolidinone cetp inhibitor |
Also Published As
Publication number | Publication date |
---|---|
CN110639018A (zh) | 2020-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW389696B (en) | Accelerated release composition containing bromocriptine | |
JP6837486B2 (ja) | 加齢に関連する認知障害及び神経炎症を予防及び/又は治療する方法 | |
JP2004517148A (ja) | 心機能不全および心不全の治療における必須n−3脂肪酸 | |
JP2006506378A5 (zh) | ||
JP6792269B2 (ja) | 夜間胃酸過分泌に対するベンズイミダゾール誘導体の使用 | |
RU2001133455A (ru) | Включающие циклоспорин композиции, практически не содержащие масла | |
AU2018222747A1 (en) | Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations | |
JP2010065060A (ja) | 心不全処置のための複合治療 | |
RU2494736C2 (ru) | Комбинация, включающая паклитаксел, для лечения рака яичников | |
JP2020522560A5 (zh) | ||
US20230071766A1 (en) | Sigma-1 receptor agonist systolic blood pressure therapy | |
JP7337435B2 (ja) | テクトリゲニン-7-0-キシロシルグルコシドを含む女性更年期症状緩和用組成物 | |
JP5296968B2 (ja) | イブプロフェン含有経口用医薬組成物 | |
CN110639018B (zh) | 一种防治老年性高血压的药物组合物及其用途 | |
JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および/または症状軽減剤 | |
JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
EP4082549A1 (en) | Drug for preventing dialysis shift or renal death | |
Erken | Amlodipine and gingival hyperplasia; case report with review of the literature | |
KR101978459B1 (ko) | 조루증 치료용 약학 조성물 및 조루증 치료 방법 | |
JP2007513991A (ja) | メタボリック症候群の処置のためのスタチンの使用 | |
JPH0564124B2 (zh) | ||
JP2021517128A (ja) | レボドパ分割用量組成物および使用 | |
CN102283831B (zh) | 一种治疗冠心病的西药复方及用途 | |
ZA200607385B (en) | Pharmaceutical composition of (+)-erythro-mefloquine and its use | |
HU212941B (en) | Process for producing synergetic, antihypertensive pharmaceutical compositions containing verapamil and trandolapril |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhou Shufen Inventor after: Mao Yichun Inventor after: Yuan Chunhua Inventor after: Xiao Hanyan Inventor after: Wang Xiaonan Inventor after: Guo Ling Inventor before: Zhou Shufen Inventor before: Mao Yichun Inventor before: Yuan Chunhua Inventor before: Xiao Hanyan Inventor before: Wang Xiaonan |
|
CB03 | Change of inventor or designer information |